PLANNED MAINTENANCE

There will be scheduled maintenance work beginning on Wednesday 26th February 2020 from 11:00 AM through to 12.00 PM (GMT).

During this time, you may not be able to log into ChemSpider. We apologise for any inconvenience this might cause and thank you for your patience.


ChemSpider 2D Image | Tanzisertib | C21H23F3N6O2

Tanzisertib

  • Molecular FormulaC21H23F3N6O2
  • Average mass448.441 Da
  • Monoisotopic mass448.183472 Da
  • ChemSpider ID28492361
  • defined stereocentres - 3 of 3 defined stereocentres


More details:






Validated by Experts, Validated by Users, Non-Validated, Removed by Users

899805-25-5 [RN]
9557
Cyclohexanol, 4-[[9-[(3S)-tetrahydro-3-furanyl]-8-[(2,4,6-trifluorophenyl)amino]-9H-purin-2-yl]amino]-, trans- [ACD/Index Name]
Tanzisertib [INN] [USAN]
Tanzisertib [Spanish] [INN]
Tanzisertib [French] [INN]
Tanzisertibum [INN]
trans-4-({9-[(3S)-Tetrahydro-3-furanyl]-8-[(2,4,6-trifluorophenyl)amino]-9H-purin-2-yl}amino)cyclohexanol [ACD/IUPAC Name]
trans-4-({9-[(3S)-Tétrahydro-3-furanyl]-8-[(2,4,6-trifluorophényl)amino]-9H-purin-2-yl}amino)cyclohexanol [French] [ACD/IUPAC Name]
trans-4-({9-[(3S)-Tetrahydro-3-furanyl]-8-[(2,4,6-trifluorphenyl)amino]-9H-purin-2-yl}amino)cyclohexanol [German] [ACD/IUPAC Name]
More...

Validated by Experts, Validated by Users, Non-Validated, Removed by Users

CC-930 [DBID]
M5O06306UO [DBID]
UNII:M5O06306UO [DBID]
UNII-M5O06306UO [DBID]
  • Experimental Physico-chemical Properties
  • Miscellaneous
    • Bio Activity:

      CC-930(Tanzisertib) is a selective and potent JNK1/JNK2/JNK3(IC50=61/7/6 nM) inhibitor and is currently under clinical development for fibrotic and infammatory indications. MedChem Express
      CC-930(Tanzisertib) is a selective and potent JNK1/JNK2/JNK3(IC50=61/7/6 nM) inhibitor and is currently under clinical development for fibrotic and infammatory indications.; IC50 Value: 61 nM (JNK1); 7 nM (JNK2); 6 nM (JNK3) [1]; Target: JNK1/2/3; in vitro: Compound 1 (CC-930) showed remarkable selectivity in a panel of 240 kinases, EGFR being the only non-MAP kinase inhibited more than 50% at 3 lM (IC50 = 0.38 lM). MedChem Express HY-15495
      CC-930(Tanzisertib) is a selective and potent JNK1/JNK2/JNK3(IC50=61/7/6 nM) inhibitor and is currently under clinical development for fibrotic and infammatory indications.;IC50 Value: 61 nM (JNK1); 7 nM (JNK2); 6 nM (JNK3) [1];Target: JNK1/2/3;In vitro: Compound 1 (CC-930) showed remarkable selectivity in a panel of 240 kinases, EGFR being the only non-MAP kinase inhibited more than 50% at 3 lM (IC50 = 0.38 lM). It inhibited no receptor at greater than 50% at 10 lM concentration in a panel of 75 receptors, ion channels and neurotransmitter transporters. Finally, when tested against 22 diverse non-kinase enzymes at 10 lM, no inhibition greater than 50% was observed [1]. Incubation with CC-930 prevented the phosphorylation of c-Jun and reduced the stimulatory levels of these cytokines on the release of collagen [2].;In vivo: Inhibition of JNK by CC-930 prevented dermal thickening, myofibroblast differentiation and the accumulation of collagen in a dose-dependent manner in mice chal MedChem Express HY-15495
      JNK MedChem Express HY-15495
      MAPK MedChem Express HY-15495
      MAPK; MedChem Express HY-15495

Predicted data is generated using the ACD/Labs Percepta Platform - PhysChem Module

Density: 1.6±0.1 g/cm3
Boiling Point: 626.4±65.0 °C at 760 mmHg
Vapour Pressure: 0.0±1.9 mmHg at 25°C
Enthalpy of Vaporization: 97.5±3.0 kJ/mol
Flash Point: 332.6±34.3 °C
Index of Refraction: 1.713
Molar Refractivity: 107.7±0.5 cm3
#H bond acceptors: 8
#H bond donors: 3
#Freely Rotating Bonds: 5
#Rule of 5 Violations: 0
ACD/LogP: 2.08
ACD/LogD (pH 5.5): 2.54
ACD/BCF (pH 5.5): 49.73
ACD/KOC (pH 5.5): 564.57
ACD/LogD (pH 7.4): 2.56
ACD/BCF (pH 7.4): 51.48
ACD/KOC (pH 7.4): 584.47
Polar Surface Area: 97 Å2
Polarizability: 42.7±0.5 10-24cm3
Surface Tension: 55.5±7.0 dyne/cm
Molar Volume: 274.6±7.0 cm3

Click to predict properties on the Chemicalize site






Advertisement